Actively Recruiting

Phase Not Applicable
Age: 13Years +
All Genders
ID06387485

A Study to Evaluate the Utilization of 3D Printed Models in Pre-Operative Planning

Led by Ricoh USA, Inc. · Updated on 2026-02-06

150

Participants Needed

3

Research Sites

13 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Researchers are evaluating the use of 3D printed models in planning surgeries to remove tumors that involve bones. This randomized controlled study will compare the effectiveness of using 3D printed models along with imaging to planning surgery using only imaging techniques such as CT or MRI. The goal is to improve surgical outcomes for patients with bone-invading tumors such as sarcoma and osteosarcoma across multiple centers and sites. Participants will be randomly assigned to one of two groups. One group will have their tumor excision planned using standard imaging techniques only, while the other group will have surgery planned with the help of patient-specific 3D printed anatomic models along with imaging. Both groups will undergo tumor removal surgery, with the study lasting about 12 months and including up to 150 subjects. Throughout the study, researchers will measure the time taken for the surgical procedure from incision to closure as the main outcome. They will also monitor blood loss during surgery, any adverse events up to 90 days after surgery, and whether the tumor was completely removed with negative margins. Additional assessments will include how easy the surgical planning was, any changes made to the plan, and the surgeon's satisfaction. Participants will undergo required imaging and surgery, with follow-up to assess safety and outcomes.

CONDITIONS

Brief Title

A Study to Evaluate the Utilization of 3D Printed Models in Pre-Operative Planning

Who Can Participate

Age: 13Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Subjects must be at least 13 years of age.
  • Subjects must be able to provide written informed consent.
  • Subjects must have tumors invading bone requiring surgical excision, including craniomaxillofacial, spine, long bone, or pelvis areas.
  • Subjects must be willing to undergo quality imaging (CT or MRI) for 3D model development.
Not Eligible

You will not qualify if you...

  • Pregnant or nursing women.
  • Subjects with serious systemic diseases.
  • Subjects with clotting disorders.
  • Subjects with uncontrolled hypertension.
  • Subjects who are HIV-positive.
  • Subjects unable to be randomized due to surgical team preference.
  • Subjects whose anatomy has changed substantially since imaging was obtained.
  • Subjects considered poor surgical or study candidates due to medical, social, or psychological reasons.

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Diagnostic Evaluation

Duration - Up to 1 week

Participants undergo imaging with CT or MRI to assess tumors and enable planning.

1 visit (in-person)

Implementation

Duration - Up to 2 weeks

Participants receive pre-surgical planning using either standard imaging alone or imaging plus a patient-specific 3D printed anatomic model before tumor excision surgery.

1 visit (in-person) for surgical planning

Surgery and Immediate Post-operative Care

Duration - Until discharge

Participants undergo tumor excision surgery based on their assigned pre-operative planning method.

1 visit (in-person) for surgery

Post-operative Follow-up

Duration - Up to 90 days

Participants are monitored for recovery and adverse events for up to 90 days after surgery.

Approximately 3 visits (in-person)

Trial Site Locations

Total: 3 locations

1

Kaiser Permanente Oakland Medical Center

Oakland, California, United States, 94611

Actively Recruiting

2

William Beaumont University Hospital

Royal Oak, Michigan, United States, 48073

Actively Recruiting

3

The Ohio State University Wexner Medical Center

Columbus, Ohio, United States, 43212

Actively Recruiting

Loading map...

Research Team

A

Alexandra Gormley, PhD

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

DIAGNOSTIC

Number of Arms

2

Similar Trials

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here